For the Inventor, By the Inventor

Enter assignee name

Assistance Publique - Hopitaux De Paris (Aphp)

USPTO Granted Patents = 71

Forward Citations = 120

Loading Chart...

Loading Chart...

164 inventors (with patents filed for the assignee):

Eli Hatchwell (8 out of 35 patents)

Peggy S Eis (8 out of 34 patents)

Edward B Smith, Iii (8 out of 12 patents)

4. Yassine Taoufik (8 out of 13 patents)

5. Olivier Hermine (6 out of 14 patents)

6. Michel Le Van Quyen (5 out of 8 patents)

7. Jerome Galon (4 out of 7 patents)

8. Franck Pages (4 out of 8 patents)

9. Thierry Poynard (4 out of 8 patents)

10. Gabriela Bindea (3 out of 3 patents)

11. Guido Kroemer (3 out of 16 patents)

12. Hafid Ait-Oufella (3 out of 5 patents)

13. Guy Gorochov (3 out of 5 patents)

14. Patrick Aubourg (3 out of 8 patents)

15. Arnold Munnich (2 out of 12 patents)

Core Competencies:

PIK3CA-Related Overgrowth Spectrum

Cardiac Fibrosis

Genetic Testing

Cancer Prognosis

FGFR3-Related Chondrodysplasias

Antibody Deficiencies

Atherosclerosis Treatment

Friedreich Ataxia

Cystic Fibrosis

Neurodegeneration

HIV Treatment

Inflammatory Bowel Diseases

71 patents: Sort by Forward Citations

1. 12427141 - BYL719 (alpelisib) for use in the treatment of PIK3CA-related overgrowth spectrum (PROS-CLOVES syndrome) (2025-09-30),

2. 12351634 - Use of cilengitide for ameliorating cardiac fibrosis occurring in response to myocardial infarction (2025-07-08),

3. 12343376 - Methods for inhibiting diazepam binding protein (2025-07-01),

4. 12331357 - Methods for assessing risk of developing a viral disease using a genetic test (2025-06-17),

5. 12318358 - Probenecid for use in treating epileptic diseases, disorders or conditions (2025-06-03),

6. 12291752 - Methods for predicting the survival time and treatment responsiveness of a patient suffering from a solid cancer with a signature of at least 7 genes (2025-05-06),

7. 12257232 - Methods and pharmaceutical compositions for the treatment of FGFR3-related chondrodysplasias (2025-03-25),

8. 12241125 - Methods for assessing risk of developing a viral disease using a genetic test (2025-03-04),

9. 12234513 - Methods for assessing risk of developing a viral disease using a genetic test (2025-02-25),

10. 12227807 - Methods for assessing risk of developing a viral disease using a genetic test (2025-02-18),

11. 12173053 - Composition for the treatment of antibody deficiencies (2024-12-24),

12. 12144859 - B cell depleting agent for the treatment of atherosclerosis (2024-11-19),

13. 12054778 - Methods for assessing risk of developing a viral disease using a genetic test (2024-08-06),

14. 11913074 - Methods for assessing risk of developing a viral disease using a genetic test (2024-02-27),

15. 11913073 - Methods for assessing risk of developing a viral disease using a genetic test (2024-02-27),

Assistance Publique - Hopitaux De Paris (APHP) is a leading public hospital system in Paris, France. With over 39 hospitals and 75,000 employees, APHP provides comprehensive and high-quality healthcare services to millions of patients each year. Their dedicated staff of doctors, nurses, and support personnel ensure that patients receive the best possible care in a state-of-the-art medical facility.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

71 Patents

#85 in Paris

#352 in France

#10,214 in the World

Assistance Publique - Hopitaux De Paris (Aphp)

Forward Citations = 120

164 inventors:

Eli Hatchwell (8 out of 35 patents)

Peggy S Eis (8 out of 34 patents)

Edward B Smith, Iii (8 out of 12 patents)

4. Yassine Taoufik (8 out of 13 patents)

5. Olivier Hermine (6 out of 14 patents)

Please report any incorrect information to support@idiyas.com

Loading…